2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane

C57H93BrN4O8 — CID 163793303

IUPAC2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane
SMILESC.CCOc1cn[nH]c1.CCOc1cnn(CC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@](C)(O)CC[C@]5(COC)[C@H]4CC[C@]23C)c1.COC[C@]12CC[C@@](C)(O)C[C@H]1CC[C@H]1[C@@H]3CC[C@H](C(=O)CBr)[C@@]3(C)CC[C@@H]12
InChIInChI=1S/C28H44N2O4.C23H37BrO3.C5H8N2O.CH4/c1-5-34-20-15-29-30(16-20)17-25(31)24-9-8-22-21-7-6-19-14-26(2,32)12-13-28(19,18-33-4)23(21)10-11-27(22,24)3;1-21(26)10-11-23(14-27-3)15(12-21)4-5-16-17-6-7-19(20(25)13-24)22(17,2)9-8-18(16)23;1-2-8-5-3-6-7-4-5;/h15-16,19,21-24,32H,5-14,17-18H2,1-4H3;15-19,26H,4-14H2,1-3H3;3-4H,2H2,1H3,(H,6,7);1H4/t19-,21+,22+,23+,24-,26-,27+,28-;15-,16+,17+,18+,19-,21-,22+,23-;;/m11../s1
InChIKeyMYRRSCNARLQZAY-NBBPWZCUSA-N
MW1042.29 g/mol
LogP11.32
Rot. Bonds13

About 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane

2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane (PubChem CID 163793303) has the molecular formula C57H93BrN4O8 and a molecular weight of 1042.29 g/mol. Its IUPAC name is 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane.

Molecular Properties

Compound Name2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane
PubChem CID163793303
Molecular FormulaC57H93BrN4O8
Molecular Weight1042.29 g/mol
Exact Mass1040.62
IUPAC Name2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane
SMILESC.CCOc1cn[nH]c1.CCOc1cnn(CC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@](C)(O)CC[C@]5(COC)[C@H]4CC[C@]23C)c1.COC[C@]12CC[C@@](C)(O)C[C@H]1CC[C@H]1[C@@H]3CC[C@H](C(=O)CBr)[C@@]3(C)CC[C@@H]12
InChIInChI=1S/C28H44N2O4.C23H37BrO3.C5H8N2O.CH4/c1-5-34-20-15-29-30(16-20)17-25(31)24-9-8-22-21-7-6-19-14-26(2,32)12-13-28(19,18-33-4)23(21)10-11-27(22,24)3;1-21(26)10-11-23(14-27-3)15(12-21)4-5-16-17-6-7-19(20(25)13-24)22(17,2)9-8-18(16)23;1-2-8-5-3-6-7-4-5;/h15-16,19,21-24,32H,5-14,17-18H2,1-4H3;15-19,26H,4-14H2,1-3H3;3-4H,2H2,1H3,(H,6,7);1H4/t19-,21+,22+,23+,24-,26-,27+,28-;15-,16+,17+,18+,19-,21-,22+,23-;;/m11../s1
InChIKeyMYRRSCNARLQZAY-NBBPWZCUSA-N
XLogP11.32
TPSA158.02 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds13
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001042.29
LogP ≤ 511.32
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane?
The IUPAC name of 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane (CID 163793303) is 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane.
What is the SMILES notation for 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane?
The canonical SMILES for 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane is C.CCOc1cn[nH]c1.CCOc1cnn(CC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@](C)(O)CC[C@]5(COC)[C@H]4CC[C@]23C)c1.COC[C@]12CC[C@@](C)(O)C[C@H]1CC[C@H]1[C@@H]3CC[C@H](C(=O)CBr)[C@@]3(C)CC[C@@H]12.
What is the InChIKey of 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane?
The InChIKey is MYRRSCNARLQZAY-NBBPWZCUSA-N. The full InChI is InChI=1S/C28H44N2O4.C23H37BrO3.C5H8N2O.CH4/c1-5-34-20-15-29-30(16-20)17-25(31)24-9-8-22-21-7-6-19-14-26(2,32)12-13-28(19,18-33-4)23(21)10-11-27(22,24)3;1-21(26)10-11-23(14-27-3)15(12-21)4-5-16-17-6-7-19(20(25)13-24)22(17,2)9-8-18(16)23;1-2-8-5-3-6-7-4-5;/h15-16,19,21-24,32H,5-14,17-18H2,1-4H3;15-19,26H,4-14H2,1-3H3;3-4H,2H2,1H3,(H,6,7);1H4/t19-,21+,22+,23+,24-,26-,27+,28-;15-,16+,17+,18+,19-,21-,22+,23-;;/m11../s1.
What are the key properties of 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane?
2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane has a molecular weight of 1042.29 g/mol, XLogP of 11.32, 13 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;4-ethoxy-1H-pyrazole;2-(4-ethoxypyrazol-1-yl)-1-[(3R,5R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10-(methoxymethyl)-3,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;methane is sourced from PubChem (CID 163793303), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).